FDA oversight of clinical trials is “grossly inadequate,” say experts

 https://www.bmj.com/content/379/bmj.o2628#:~:text=FDA%20oversight%20of%20clinical%20trials%20is%20%E2%80%9Cgrossly%20inadequate%2C%E2%80%9D%20say%20experts,-BMJ%202022%3B%20379&text=On%2025%20September%202020%2C%20the,Pfizer's%20covid%2D19%20mRNA%20vaccine.